Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.

The present study used isobaric tags for relative and absolute quantitation (iTRAQ) to identify novel targets in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. The expression of 41 proteins was significantly altered in the inflamed spinal cord. Twenty of these are implicated in EAE for the first time and many have previously been shown to play a role in antigen processing, inflammation, neuroprotection, or neurodegeneration.

[1]  R. Pearlstein,et al.  Protective effect of apolipoprotein E-mimetic peptides on N-methyl-d-aspartate excitotoxicity in primary rat neuronal–glial cell cultures , 2003, Neuroscience.

[2]  M. Reindl,et al.  Increased intrathecal production of apolipoprotein D in multiple sclerosis , 2001, Journal of Neuroimmunology.

[3]  Justin C McArthur,et al.  Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis , 2006, Annals of neurology.

[4]  H. Lassmann,et al.  Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination , 1998, Annals of neurology.

[5]  D. Michaelson,et al.  Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis , 2003, Multiple sclerosis.

[6]  R. Gold,et al.  Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. , 2001, Brain : a journal of neurology.

[7]  L. Lannfelt,et al.  APOE genotypes and disease severity in multiple sclerosis , 2002, Multiple sclerosis.

[8]  D. Pitt,et al.  Glutamate uptake by oligodendrocytes , 2003, Neurology.

[9]  S. Lynch,et al.  Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients , 1999, Brain Research.

[10]  Elke Krüger,et al.  Interferon‐γ, the functional plasticity of the ubiquitin–proteasome system, and MHC class I antigen processing , 2005, Immunological reviews.

[11]  Masahiko Watanabe,et al.  Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.

[12]  A. Rivett,et al.  Regulation of proteasome complexes by γ-interferon and phosphorylation , 2001 .

[13]  R. Pearlstein,et al.  Apolipoprotein E protects against oxidative stress in mixed neuronal–glial cell cultures by reducing glutamate toxicity , 2004, Neurochemistry International.

[14]  C. Bever,et al.  Increased cathepsin B activity in multiple sclerosis brain , 1995, Journal of the Neurological Sciences.

[15]  Stella Elkabes,et al.  Temporal pattern of plasma membrane calcium ATPase 2 expression in the spinal cord correlates with the course of clinical symptoms in two rodent models of autoimmune encephalomyelitis , 2005, The European journal of neuroscience.

[16]  H. Kiyama,et al.  Annexin III implicated in the microglial response to motor nerve injury , 2006, Glia.

[17]  L. Bö,et al.  Basement Membrane Proteins in Multiple Sclerosis-Associated Inflammatory Cuffs: Potential Role in Influx and Transport of Leukocytes , 2005, Journal of neuropathology and experimental neurology.

[18]  M. Ramanathan,et al.  In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects , 2001, Journal of Neuroimmunology.

[19]  A. Rolfs,et al.  Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process , 2004, Journal of Neuroimmunology.

[20]  B. Trapp,et al.  Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions , 1994, Journal of Neuroimmunology.

[21]  G I Murray,et al.  Proteomics: a new approach to the study of disease , 2000, The Journal of pathology.

[22]  S. Moss,et al.  Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.

[23]  Yan Liu,et al.  Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. , 2006, Journal of Alzheimer's disease : JAD.

[24]  Dijkstra,et al.  Effect of annexin‐1 on experimental autoimmune encephalomyelitis (EAE) in the rat , 1998, Clinical and experimental immunology.

[25]  D Gveric,et al.  Astrocyte characterization in the multiple sclerosis glial scar , 2002, Neuropathology and applied neurobiology.

[26]  R. Birge,et al.  A multiplexed proteomics approach to differentiate neurite outgrowth patterns , 2006, Journal of Neuroscience Methods.

[27]  F. Sallusto,et al.  Dendritic cells up‐regulate immunoproteasomes and the proteasome regulator PA28 during maturation , 1999, European journal of immunology.

[28]  P. Kloetzel,et al.  Differential Expression Regulation of the α and β Subunits of the PA28 Proteasome Activator in Mature Dendritic Cells1 , 2005, The Journal of Immunology.

[29]  M. R. Wall,et al.  A distinctive molecular signature of multiple sclerosis derived from MALDI-TOF/MS and serum proteomic pattern analysis , 2007, Journal of Molecular Neuroscience.

[30]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[31]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[32]  Richard H. Price,et al.  Black Holes , 1997 .

[33]  Jean-Paul Noben,et al.  Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients , 2004, Proteomics.

[34]  C. Bever,et al.  Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients , 1994, Neurology.

[35]  Y. Christen,et al.  Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. , 2001, Brain research. Molecular brain research.

[36]  Lawrence Steinman,et al.  Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis , 2003, Nature Biotechnology.

[37]  P. Matthews,et al.  Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4 , 2004, Annals of neurology.

[38]  D. Pitt,et al.  Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.

[39]  T. Colgan,et al.  Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. , 2005, Journal of proteome research.

[40]  B. Engelhardt,et al.  Gene and Protein Expression Profiling of the Microvascular Compartment in Experimental Autoimmune Encephalomyelitis in C57BI/6 and SJL Mice , 2005, Brain pathology.

[41]  C. Warren Olanow,et al.  Altered Proteasomal Function in Sporadic Parkinson's Disease , 2003, Experimental Neurology.

[42]  L. Griffiths,et al.  Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. , 2003, Brain research. Molecular brain research.

[43]  Joshua E. Elias,et al.  Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. , 2003, Journal of proteome research.

[44]  L. Turski,et al.  Autoimmune encephalomyelitis ameliorated by AMPA antagonists , 2000, Nature Medicine.

[45]  K. Kosik,et al.  Suppression of Radixin and Moesin Alters Growth Cone Morphology, Motility, and Process Formation In Primary Cultured Neurons , 1998, The Journal of cell biology.

[46]  S. Sorbi,et al.  Influence of Apolipoprotein E ϵ4 Genotype on Brain Tissue Integrity in Relapsing-Remitting Multiple Sclerosis , 2004 .

[47]  R. Ravid,et al.  Increased expression and function of glutamate transporters in multiple sclerosis , 2006, Neurobiology of Disease.

[48]  H. Hartung,et al.  Lipocortin-1 (annexin-1) suppresses activation of autoimmune T cell lines in the Lewis rat , 1996, Journal of Neuroimmunology.

[49]  S Ropele,et al.  Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[50]  D. Davidson,et al.  Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients , 1985, Neurochemical Research.

[51]  J. Robben,et al.  Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry. , 2006, Journal of proteome research.

[52]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[53]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[54]  P. Sundström,et al.  Native and transformed α2‐macroglobulin in plasma from patients with multiple sclerosis , 2003, Acta neurologica Scandinavica.

[55]  Y. Eishi,et al.  Hepatoma‐derived growth factor, a new trophic factor for motor neurons, is up‐regulated in the spinal cord of PQBP‐1 transgenic mice before onset of degeneration , 2006, Journal of neurochemistry.

[56]  N. Bowern,et al.  Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin. , 1991, Immunology.

[57]  C. Colton,et al.  Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis , 2006, Journal of Pharmacology and Experimental Therapeutics.

[58]  A. Lo,et al.  Annexin II/p11 is up-regulated in Purkinje cells in EAE and MS , 2003, Neuroreport.

[59]  D. Barry,et al.  The distribution of immunoglobulins and albumin in the central nervous system in acute experimental allergic encephalomyelitis , 1986, Acta neurologica Scandinavica.

[60]  Yan Li,et al.  Optimized proteomic analysis of a mouse model of cerebellar dysfunction using amine‐specific isobaric tags , 2006, Proteomics.

[61]  J. Vickers,et al.  Binding partners L1 cell adhesion molecule and the ezrin‐radixin‐moesin (ERM) proteins are involved in development and the regenerative response to injury of hippocampal and cortical neurons , 2004, The European journal of neuroscience.

[62]  D. Walker,et al.  Vimentin immunoreactivity in normal and pathological human brain tissue , 2004, Acta Neuropathologica.

[63]  C. Siao,et al.  Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II , 2002, The Journal of Neuroscience.

[64]  Murray Grant,et al.  Analysis of the defence phosphoproteome of Arabidopsis thaliana using differential mass tagging , 2006, Proteomics.

[65]  J. Relton,et al.  Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat , 1992, Brain Research.

[66]  D. Lauffenburger,et al.  Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules*S , 2005, Molecular & Cellular Proteomics.

[67]  Y. Ron,et al.  Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. , 2003, Brain : a journal of neurology.

[68]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[69]  S. Sakoda,et al.  Hepatoma-derived Growth Factor Is a Neurotrophic Factor Harbored in the Nucleus* , 2004, Journal of Biological Chemistry.

[70]  F. Gay,et al.  Early cellular events in multiple sclerosis Intimations of an extrinsic myelinolytic antigen , 2006, Clinical Neurology and Neurosurgery.

[71]  D. Ashline,et al.  Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. , 2002, Free radical biology & medicine.

[72]  E. Choi,et al.  Inhibition of Cytosolic Phospholipase A2 by Annexin I , 2001, The Journal of Biological Chemistry.

[73]  R. Kiessling,et al.  Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. , 2001, Blood.

[74]  C. Bessant,et al.  i-Tracker: For quantitative proteomics using iTRAQ™ , 2005, BMC Genomics.

[75]  P. Sørensen,et al.  Significantly increased fractions of transformed to total alpha2-macroglobulin concentrations in plasma from patients with multiple sclerosis. , 2004, Biochimica et biophysica acta.

[76]  S. Hunsucker,et al.  Proteomic analysis of multiple sclerosis cerebrospinal fluid , 2004, Multiple sclerosis.

[77]  R. Campenot,et al.  The synthesis and transport of lipids for axonal growth and nerve regeneration. , 2000, Biochimica et biophysica acta.

[78]  R. Flower,et al.  The detection of lipocortins 1, 2 and 5 in central nervous system tissues from Lewis rats with acute experimental allergic encephalomyelitis , 1990, Journal of Neuroimmunology.

[79]  S. Sorbi,et al.  Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. , 2004, Archives of neurology.

[80]  D. Michaelson,et al.  APOE genotype is a major predictor of long-term progression of disability in MS , 2001, Neurology.

[81]  J. Haines,et al.  APOE epsilon variation in multiple sclerosis susceptibility and disease severity , 2006, Neurology.

[82]  R. Sobel,et al.  Fibronectin in multiple sclerosis lesions. , 1989, The American journal of pathology.

[83]  L. Murray,et al.  Involvement of Apolipoprotein E in Multiple Sclerosis: Absence of Remyelination Associated with Possession of the APOE ε2 Allele , 2000, Journal of neuropathology and experimental neurology.

[84]  J. Newcombe,et al.  Extraction and proteomic analysis of proteins from normal and multiple sclerosis postmortem brain. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[85]  A. Roses,et al.  Apolipoprotein E and the CNS Response to Injury , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.